Elsevier

Annals of Oncology

Volume 22, Issue 11, November 2011, Pages 2375-2380
Annals of Oncology

original articles
palliative care
Palliative chemotherapy during the last month of life

https://doi.org/10.1093/annonc/mdq778Get rights and content
Under an Elsevier user license
open archive

Abstract

Background

This study analyses the potential discriminative characteristics for patients with incurable cancer who received palliative chemotherapy during their last month of life.

Patients and methods

The study includes all patients with epithelial cancer treated with palliative chemotherapy who died in 2008 in northern Sweden. Demographic parameters and care utilization data were registered. Data were analyzed using nonparametric methods.

Results

Of 374 included patients, 87 (23%) received chemotherapy during the last month of life. These patients had a significantly shorter survival time from first palliative treatment to death, were admitted more frequently to hospital, more often lacked a documented decision to cease treatment, and died less frequently at home.

Conclusions

The results indicate covariations between palliative chemotherapy treatments in the last month of life and unfavorable patient outcomes. As almost one of four patients with incurable cancer received their last round of palliative chemotherapy <31 days before death, there is a potential for improved routines.

Keywords

cancer
chemotherapy
decision making
palliative treatment
retrospective study

Cited by (0)